Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LPTX |
---|---|---|
09:32 ET | 2789 | 2.69 |
09:33 ET | 712 | 2.5655 |
09:35 ET | 100 | 2.6181 |
09:37 ET | 701 | 2.5623 |
09:42 ET | 1100 | 2.616 |
09:44 ET | 5000 | 2.556 |
09:46 ET | 14393 | 2.7 |
09:48 ET | 300 | 2.6 |
09:50 ET | 369 | 2.6 |
09:53 ET | 250 | 2.5613 |
09:55 ET | 648 | 2.625 |
10:06 ET | 200 | 2.61 |
10:13 ET | 100 | 2.64 |
10:15 ET | 100 | 2.64 |
10:22 ET | 624 | 2.635 |
10:26 ET | 100 | 2.6343 |
10:36 ET | 200 | 2.65 |
10:40 ET | 1000 | 2.635 |
10:47 ET | 1200 | 2.64 |
10:49 ET | 100 | 2.64 |
11:03 ET | 200 | 2.63 |
11:05 ET | 200 | 2.63 |
11:07 ET | 100 | 2.62 |
11:09 ET | 100 | 2.62 |
11:16 ET | 100 | 2.64 |
11:18 ET | 2700 | 2.64 |
11:20 ET | 600 | 2.62 |
11:25 ET | 100 | 2.6385 |
11:27 ET | 917 | 2.62 |
11:30 ET | 11710 | 2.61 |
11:32 ET | 500 | 2.6 |
11:34 ET | 500 | 2.5801 |
11:39 ET | 650 | 2.62 |
11:43 ET | 100 | 2.62 |
11:48 ET | 7006 | 2.66 |
11:50 ET | 700 | 2.7 |
11:54 ET | 9868 | 2.69 |
11:57 ET | 1210 | 2.67 |
11:59 ET | 2100 | 2.685 |
12:01 ET | 150 | 2.6969 |
12:03 ET | 100 | 2.69 |
12:10 ET | 6400 | 2.72 |
12:12 ET | 3985 | 2.73 |
12:14 ET | 1400 | 2.7199 |
12:21 ET | 1997 | 2.71 |
12:26 ET | 200 | 2.725 |
12:30 ET | 100 | 2.725 |
12:32 ET | 1960 | 2.755 |
12:33 ET | 979 | 2.755 |
12:35 ET | 300 | 2.7201 |
12:39 ET | 2300 | 2.755 |
12:42 ET | 3400 | 2.755 |
12:46 ET | 220 | 2.775 |
12:48 ET | 500 | 2.78 |
12:50 ET | 432 | 2.7949 |
12:53 ET | 2260 | 2.79 |
01:02 ET | 1100 | 2.79 |
01:04 ET | 6369 | 2.82 |
01:08 ET | 1800 | 2.82 |
01:22 ET | 1623 | 2.83 |
01:26 ET | 5199 | 2.815 |
01:27 ET | 3120 | 2.81 |
01:31 ET | 250 | 2.8001 |
01:33 ET | 2609 | 2.805 |
01:38 ET | 5195 | 2.77 |
01:40 ET | 100 | 2.775 |
02:00 ET | 2399 | 2.7899 |
02:02 ET | 300 | 2.78 |
02:03 ET | 200 | 2.78 |
02:05 ET | 834 | 2.78 |
02:09 ET | 1600 | 2.76 |
02:12 ET | 200 | 2.76 |
02:14 ET | 100 | 2.76 |
02:20 ET | 2650 | 2.765 |
02:21 ET | 185 | 2.7532 |
02:23 ET | 380 | 2.755 |
02:25 ET | 210 | 2.74 |
02:32 ET | 2620 | 2.7101 |
02:45 ET | 1550 | 2.695 |
02:48 ET | 900 | 2.695 |
02:50 ET | 800 | 2.69 |
02:52 ET | 200 | 2.7 |
02:54 ET | 400 | 2.74 |
02:56 ET | 100 | 2.715 |
02:57 ET | 5809 | 2.7 |
02:59 ET | 500 | 2.69 |
03:01 ET | 554 | 2.69 |
03:03 ET | 1000 | 2.69 |
03:06 ET | 8200 | 2.72 |
03:10 ET | 100 | 2.7426 |
03:14 ET | 5890 | 2.7 |
03:17 ET | 200 | 2.6994 |
03:24 ET | 100 | 2.69 |
03:26 ET | 200 | 2.695 |
03:28 ET | 245 | 2.68 |
03:30 ET | 1000 | 2.6874 |
03:35 ET | 100 | 2.69 |
03:44 ET | 100 | 2.695 |
03:46 ET | 100 | 2.71 |
03:48 ET | 1739 | 2.71 |
03:50 ET | 220 | 2.71 |
03:51 ET | 731 | 2.71 |
03:53 ET | 2476 | 2.7 |
03:55 ET | 200 | 2.6823 |
03:57 ET | 301 | 2.7 |
04:00 ET | 3362 | 2.72 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Leap Therapeutics Inc | 67.5M | -0.5x | --- |
NKGen Biotech Inc | 66.5M | -0.9x | --- |
Checkpoint Therapeutics Inc | 68.0M | -0.6x | --- |
Kronos Bio Inc | 68.8M | -0.6x | --- |
BioVie Inc | 65.7M | -1.2x | --- |
Bioatla Inc | 65.7M | -0.5x | --- |
Leap Therapeutics, Inc. is a biotechnology company. The Company is focused on developing targeted and immuno-oncology therapeutics. Its advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patients with esophagogastric, gynecologic, and colorectal cancers. DKK1 modulates the Wnt/Beta-catenin and PI3kinase/AKT signaling pathways and promotes tumor proliferation, metastasis, angiogenesis, and in mediating an immune suppressive tumor microenvironment through enhancing the activity of myeloid-derived suppressor cells and downregulating NK cell ligands on tumor cells. The Company’s pipeline includes FL-301, a humanized monoclonal antibody targeting Claudin18.2, being developed in patients with gastric and pancreatic cancer. Claudin18.2 regulates barrier properties and contributes to cell-to-cell adhesion. It also has preclinical antibody programs targeting Claudin18.2/CD137 and GDF15.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $67.5M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 25.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.40 |
EPS | $-5.72 |
Book Value | $5.94 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.